Register for a live webcast-"A New CD38-Directed Antibody for the Treatment of Appropriate Relapsed Refractory Multiple Myeloma Patients"

COVID-19 and Cancer: Oncologist Shares His View

ADITYA BARDIA, MD, MPH
Thursday, March 12, 2020


Aditya Bardia, MD, MPH, attending physician at Massachusetts General Hospital and assistant professor of medicine at Harvard Medical School, discusses COVID-19 (Coronavirus) risk in patients with cancer and the elderly.

Transcription

We don't have the answers yet in terms of how COVID-19 will impact immunocompromised patients. We do know from what was seen in China that elderly patients were the ones who were at higher risk of having a more serious infection. One can anticipate that immunocompromised patients might also have a more severe form of infection.

Having said that, there's a lot of development that's going on in terms of developing assays to detect this disease earlier. And [there's] also a lot of work being done on vaccines. So there's a lot of work being done which could change the natural history of this disease.

Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.
Related Videos
By: Patrick I. Borgen, MD
External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives


About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.